Cell immortalization

GINYS-IJC-007
The Cell Immortalization Unit of the Josep Carreras Leukemia Research Institute offers B-cell infection with Epstein-Barr virus (EBV) which leads to further and subsequent immortalization. This is considered the method of choice for generating lymphoblastoid cell lines (LCL). Cell culture is an essential tool for studying the fundamentals of genetic background variables. With the development of personalized medicine, this is increasingly applied to the development and safety testing of drugs. Immortalized cells are derived from primary cells, thus establishing an immortalized cell line to achieve cultured cells in vitro. The purpose of unlimited proliferation and no difference between cells. The Cell Immortalization Unit works closely with you in an integrated manner starting with the project discussion (including the project outline and experimental design). we are continuously working to optimize standard operating procedures and implement the latest methodologies. With our personalized service, you can get our high quality customer service experience with high success rates, frequent communication and fast deadlines.

Services

  • Cell immortalization service to generate cell lines of lymphocytes
  • Produce control material for rare genetic disorders
  • Cryopreservation service to obtain sufficient material from DNA, RNA, and protein samples, which appears to be a valid strategy for further studies.

Staff

Carolina De La Torre | cdelatorre@carrerasresearch.org | 935 572 800 (Mon-Fri 08.30-17.30) | ORCID | PRC Page

Publications

The impact of MECP2 mutations in the expression patterns of Rett syndrome patients
Ballestar E, Ropero S, Alaminos M, Armstrong J, Setien F, Agrelo R, Fraga MF, Herranz M, Avila S, Pineda M, Monros E, Esteller M.
Hum Genet. 2005 Jan;116(1-2):91-104
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma
Berdasco M, Ropero S, Setien F, Fraga MF, Lapunzina P, Losson R, Alaminos M, Cheung NK, Rahman N, Esteller
M. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21830-5
A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies
Agrelo R, Sutz MA, Setien F, Aldunate F, Esteller M, Da Costa V, Achenbach
R. Epigenetics. 2015;10(4):329-41
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families
Calvete O, Martinez P, Garcia-Pavia P, Benitez-Buelga C, Paumard-Hernández B, Fernandez V, Dominguez F, Salas C, Romero-Laorden N, Garcia-Donas J, Carrillo J, Perona R, Triviño JC, Andrés R, Cano JM, Rivera B, Alonso-Pulpon L, Setien F, Esteller M, Rodriguez-Perales S, Bougeard G, Frebourg T, Urioste M, Blasco MA, Benítez
J. Nat Commun. 2015 Sep 25; 6:8383
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene
Cascón A, Comino-Méndez I, Currás-Freixes M, de Cubas AA, Contreras L, Richter S, Peitzsch M, Mancikova V, Inglada-Pérez L, Pérez-Barrios A, Calatayud M, Azriel S, Villar-Vicente R, Aller J, Setién F, Moran S, Garcia JF, Río-Machín A, Letón R, Gómez-Graña Á, Apellániz-Ruiz M, Roncador G, Esteller M, Rodríguez-Antona C, Satrústegui J, Eisenhofer G, Urioste M, Robledo M.
J Natl Cancer Inst. 2015 Mar 11;107(5):djv053
Germline missense pathogenic variants in the BRCA1 BRCT domain, p. Gly1706Glu and p. Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect
Vaclová T, Woods NT, Megías D, Gomez-Lopez S, Setién F, García Bueno JM, Macías JA, Barroso A, Urioste M, Esteller M, Monteiro ANA, Benítez J, Osorio A.
Hum Mol Genet. 2016 Dec 15;25(24):5287-5299
Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis
Mur P, De Voer RM, Olivera-Salguero R, Rodríguez-Perales S, Pons T, Setién F, Aiza G, Valdés-Mas R, Bertini A, Pineda M, Vreede L, Navarro M, Iglesias S, González S, Brunet J, Valencia A, Esteller M, Lázaro C, Kops GJPL, Urioste M, Puente XS, Capellá G, Valle L.
Mol Cancer. 2018 Feb 15;17(1):23

INSTITUTE

IJC - Institut de Recerca Contra la Leucèmia Josep Carreras

Campus Can Ruti - Edifici IJC
Ctra. de Can Ruti
Camí de les escoles, s/n

08916 Badalona https://www.carrerasresearch.org/ca

DOMAINS RIS3CAT

  • Education and knowledge generation system
  • Industrial system
  • Socio-sanitary system

CATEGORIES

  • TECHNOLOGICAL EQUIPMENT
    • Other specializated laboratories

RATES AND ACCESS

Access Procedures:

Open

CERCA - Ginys